Salem Partners

Salem Partners provides investment banking and strategic advisory services to emerging growth companies in the pharmaceutical, biotechnology, healthcare services, medical device, and healthcare IT sectors. It has advised on capital raising, M&A transactions, and licensing deals for specialty pharma and biotech clients but does not develop its own clinical pipeline. Notable transactions include acting as exclusive financial advisor for Femasys’s $44M Series C financing for women’s health devices and raising venture capital for ZS Pharma prior to its acquisition by AstraZeneca. The firm also supported OncoNano Medicine in securing $50M Series B funding for cancer diagnostics technology. It has helped multiple life sciences companies reach IPO or acquisition. No direct clinical results or programs attributable to Salem Partners itself.